View T-Oph overdosage for action to be taken in the event of an overdose.
Contraindications
Hypersensitivity. Patients w/ or w/ history of bronchial asthma. Severe COPD, sinus bradycardia, AV block >1st degree, overt cardiac failure, or cardiogenic shock.
Discontinue at 1st sign or symptom of cardiac failure; in cerebrovascular insufficiency. History of atopy or severe anaphylaxis. Anesth during major surgery; protracted severe hypotension, difficulty maintaining heart rate; choroidal detachment after filtration procedures; mild or moderate COPD; DM; myasthenic conditions. May mask symptoms of acute hypoglycemia; clinical signs of hyperthyroidism eg, tachycardia. Not to be used in angle-closure glaucoma as monotherapy. Increased risk of exacerbation or precipitation; reduced cerebral blood flow. Consider dose reduction prior to surgery. Avoid abrupt w/drawal in suspected thyrotoxicosis. Systemic absorption may occur. Not recommended in concomitant use w/ 2nd topical β-blocker. Avoid concomitant use w/ Ca antagonists in patients w/ impaired cardiac function. Pregnancy & lactation.
Sign Out
